Typhoid vaccine
From Wikipedia, the free encyclopedia
Not to be confused with typhus vaccine.
| Vaccine description | |
|---|---|
| Target disease | Typhoid |
| Type | ? |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a607028 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | J07AP01 J07AP02 J07AP03 J07AP10 |
 (what is this?) (verify) |
|
Typhoid vaccine is a vaccine used against typhoid fever.
There are two effective types:[1]
- Ty21a, which is a live vaccine
- Vi capsular polysaccharide vaccine, which is a subunit vaccine
Almroth Edward Wright developed an effective inactivated whole-cell typhoid vaccine that was introduced in 1896.[1] Due to side-effects its usage was eventually discontinued. An experimental vaccine called Vi-rEPA has showed promising results in trials so far, indicating higher effectiveness and longer immunity. However, it has yet to be licensed for use.[1]
[edit] References
 |
This vaccine article is a stub. You can help Wikipedia by expanding it. |
